Madison Area Lyme Support Group

What has been presented here in Tomorrow’s Cure is the same old dogma propagated for decades by those who have controlled this false public heath narrative.

Dr. Allen Steere would be doing us all a favor by retiring.

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “tomorrowscure@mayo.edu” <tomorrowscure@mayo.edu>
Cc: “newsbureau@mayo.edu” <newsbureau@mayo.edu>, “cwurzer@mpr.org” <cwurzer@mpr.org>, “asteere@mgh.harvard.edu” <asteere@mgh.harvard.edu>, “Pritt.bobbi@mayo.edu” <Pritt.bobbi@mayo.edu>
Date: 07/13/2025 3:00 PM EDT
Subject: Tomorrow’s Cure: New frontiers in Lyme disease detection — just in time for summer

Tomorrow’s Cure: New frontiers in Lyme disease detection — just in time for summer

Deb Balzer July 2, 2025
https://newsnetwork.mayoclinic.org/discussion/tomorrows-cure-new-frontiers-in-lyme-disease-detection-just-in-time-for-summer/

“Dr. Steere identified Lyme disease in 1976 while investigating a cluster of children in Lyme, Connecticut, who were experiencing unexplained arthritis. His research ultimately led to the discovery and naming of the disease. Since then, researchers have devoted their efforts to advancing diagnostic tools, treatments and vaccine development.”

Mayo Clinic “Tomorrow’s Cure” podcast
Attn: Cathy Wurzer, Host

Dear Cathy,

Thirty-five  years ago Dr. Allen Steere identified chronic Lyme disease which should have set off a red flag prompting an immediate search for better antimicrobials but then did a 180° as he became principal investigator (PI) of the Phase 3 clinical trial for the first Lyme disease vaccine. So all the eggs were put into the vaccine basket while a campaign was orchestrated to discredit the sick and disabled patient population along with the courageous clinicians attempting to help these patients. Apparently, a chronic relapsing seronegative disease did not fit the business model of patent royalties, vaccine development and pharmaceutical profits. That rush to create a Lyme vaccine early in the discovery phase (of the Lyme epidemic) eliminated the research desperately needed to find a cure for an infection that was not responding to antibiotic treatment as reported by Dr. Allen Steere in 1990 and the disabled Lyme community ever since.

Here is Dr. Steere’s 1990 publication summary for your review:

The New England Journal of Medicine 

Published November 22, 1990

Chronic neurologic manifestations of Lyme disease
https://www.nejm.org/doi/full/10.1056/NEJM199011223232102

This is what Steere was reporting in 1977:

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. (1977)
Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM.
https://www.ncbi.nlm.nih.gov/pubmed/836338

Excerpt:

“The best treatment for this illness is not clear. Some physicians have reported that penicillin or tetracycline results in disappearance of the skin lesion (41,42), but others find antibiotics ineffective. Four of the patients with expanding skin lesions received penicillin but still developed arthritis.”

__________________________

In 1991 the Lyme disease organism, Borrelia burgdorferi, was grown from the cerebrospinal fluid of Lyme patient Vicki Logan at the Centers for Disease Control in Fort Collins, Colorado despite prior treatment with intravenous antibiotics. The patient died when the insurer refused additional IV antibiotics. Here is a copy of Logan’s CDC positive culture report for your review.

(Vicki Logan’s Chronic Lyme Autopsy results Page #1, 2, 3, 4, 5, 6, 7)

The destructive nature of Borrelia is evident in Vicky Logan’s liver (nutmeg liver), kidneys, heart, lungs and brain. The patient died after the insurer refused additional IV antibiotic therapy.

There are 700 peer-reviewed publications referencing persistent infection and in a 2018 study all patients were culture positive even after multiple years on antibiotics so there was no relief from current antimicrobials. Some of these patients had taken as many as eleven different types of antibiotics.

Quotes from the Tomorrow’s Cure podcast

Lyme disease testing:

Quote from Dr Pritt @ 15:11min into the podcast…

“…but later on, the antibody tests that we have are quite good at detecting those late-stage manifestations…”

1. Serology is so unreliable that in 2013 Virginia Governor Bob McDonnell signed HB1933 into law requiring healthcare providers to notify those tested that current laboratory testing can produce false negatives.

2. Governor Chris Sununu’s 2020-2021 commission to study diagnostic testing for Lyme disease  concluded that the FDA approved two-tier serologic immunoassay for Lyme was not reliable in all stages of disease; no better than a coin toss.
 
3. Peer-reviewed evidence of “Seronegativity in Lyme borreliosis and Other Spirochetal Infections” 16 September 2003  https://www.dropbox.com/s/3d6m45jzlhhwalu/Seronegativity.pdf?dl=0

4. I would like to point out the following case study from Stony Brook Lyme clinic. I understand the patient received thirteen spinal taps, multiple courses of IV and oral meds, and relapsed after each one, proven by CSF antigens and/or PCR. The only way this patient (said to be a physician) remained in remission was to keep her on open ended clarithromycin- was on it for 22 months by the time of publication.

Seronegative Chronic Relapsing Neuroborreliosis.
https://www.ncbi.nlm.nih.gov/pubmed/7796837

Lawrence C.a · Lipton R.B.b · Lowy F.D.c · Coyle P.K.d

aDepartment of Medicine, bDepartment of Neurology, and cDivision of Infectious Diseases, Albert Einstein College of Medicine, and dDepartment of Neurology, State University of New York at Stony Brook, New York, NY., USA

Eur Neurol 1995; 35:113–117 (DOI:10.1159/000117104)

Abstract

We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.

Lyme disease vaccines:

Quotes from Dr Steere:

@ 26:41min: “I think we’ve had an effective and save vaccine for Lyme disease for over twenty years.”

@ 27:49 min: “From antivaccine movements the manufacturer decided it just was not worth the risk.”

This was not an “antivaccine movement” as there was substantial risk of serious harm to public health!

REPORT ON LYlMErix
Prepared by: SHELLER, LUDWIG & BADEY
Submitted to: VACCINES AN-D RELATED BIOLOGICAL PRODUSTS ADVISORY COMMITTEE   Jan 31, 2001

Excerpt:

The people who have contacted us were, prior to vaccination with LYMErix, healthy, active and energetic. Indeed, the very reason they sought the LYMErix vaccine was their desire to preserve their healthy, active lifestyle. However, what they experienced was a dramatic degradation of their health and quality of life. As will be described below, these previously healthy individuals are now afflicted with painful, at times debilitating arthritic symptoms, including joint pain and swelling, as well as extremely severe Lyme-disease-like symptoms which have persisted to this day.

LymeRix Vaccine Victim’s Stories and Related- Articles
https://www.dropbox.com/scl/fi/0jxjhg58v4zey5bl3s1xj/LYMErix-Vaccine-Victims-Stories-FDA-Jan-2001.pdf?rlkey=vmicwpln1e850otvtal0mw9y6&dl=0

JUDGEMENT, FINAL ORDER AND DECREE GRANTING FINAL APPROVAL OF THE CLASS ACTION SETTLEMENT:
https://www.lymedisease.org/wp-content/uploads/2018/05/2003-Vaccine-Judgement.pdf

What has been presented here in Tomorrow’s Cure is the same old dogma propagated for decades by those who have controlled this false public heath narrative.

Mark Twain once said, “It is easier to fool people than to convince them that they have been fooled.”

Has the wool been pulled over your eyes Cathy Wurzer?

Carl Tuttle
Independent Researcher
Hudson, NH
 
Letter to the editor published in BMJ June 10, 2020
Re: Lyme borreliosis: diagnosis and management
https://www.bmj.com/content/369/bmj.m1041/rr-1